| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.10▼ | 3.11▼ | 3.11▼ | 3.20▼ | 2.86▲ |
| MA10 | 3.11▼ | 3.11▼ | 3.11▼ | 3.12▼ | 3.04▲ |
| MA20 | 3.11▼ | 3.12▼ | 3.16▼ | 2.92▲ | 3.93▼ |
| MA50 | 3.10▼ | 3.18▼ | 3.16▼ | 3.10▼ | 6.53▼ |
| MA100 | 3.13▼ | 3.14▼ | 3.00▲ | 4.10▼ | 6.06▼ |
| MA200 | 3.18▼ | 2.96▲ | 2.86▲ | 6.30▼ | 5.71▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.002▲ | -0.011▼ | 0.052▲ | 0.054▲ |
| RSI | 33.523▼ | 41.734▼ | 43.624▼ | 52.061▲ | 33.691▼ |
| STOCH | 0.000▼ | 51.631 | 47.981 | 78.161 | 25.928 |
| WILL %R | -100.000▼ | -61.111 | -72.000 | -32.558 | -65.089 |
| CCI | -116.667▼ | -43.137 | -83.721 | 33.845 | -17.899 |
| MA | $BCRX Price Crossed Below MA(50) | Set Alert |
|
Wednesday, September 11, 2019 08:52 AM
KVD900 phase 1 data may make it look better than competitor BioCryst's (NASDAQ:BCRX) HAE candidate. However, BioCryst is in an advanced stage with phase 3 trial on patients, with safety and ...
|
|
Tuesday, September 10, 2019 05:44 AM
Durham-based BioCryst Pharmaceuticals (Nasdaq: BCRX) is quickly heading toward the possible approval of its main drug candidate – BCX7353, an oral product designed to treat hereditary angioedema ...
|
|
Monday, September 09, 2019 05:57 AM
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) has witnessed a serious downturn in its share price since 21/05/19 when it recently presented data from its Phase III clinical trial (APeX-2 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/09/19 | 3.16 | 3.20 | 3.01 | 3.08 | 823,700 |
| 12/09/19 | 3.30 | 3.30 | 3.10 | 3.15 | 1,057,800 |
| 11/09/19 | 3.33 | 3.36 | 3.20 | 3.29 | 1,097,100 |
| 10/09/19 | 3.14 | 3.33 | 3.10 | 3.33 | 1,638,200 |
| 09/09/19 | 3.17 | 3.19 | 3.06 | 3.15 | 785,800 |
| 06/09/19 | 3.14 | 3.23 | 3.04 | 3.14 | 1,614,100 |
| 05/09/19 | 2.99 | 3.20 | 2.945 | 3.14 | 1,377,874 |
| 04/09/19 | 3.00 | 3.04 | 2.85 | 2.94 | 1,403,800 |
| 03/09/19 | 2.97 | 2.9855 | 2.825 | 2.96 | 1,426,533 |
| 30/08/19 | 3.00 | 3.00 | 2.85 | 2.99 | 663,705 |
|
|
||||
|
|
||||
|
|